[Next-Generation Sequencing Tests for Malignant Brain Tumors].

Abstract excerpt

The cancer genome-profiling test is performed to analyze exome gene mutations, amplifications, deletions, fusion gene expression, etc. in tumor tissues with a next-generation sequencer to identify tumor-specific driver genes. The cancer genome-profiling test is covered by medical insurance for patients with malignant brain tumors in Japan, but it is limited to patients with good PS(performance status),...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Mutation
• Share to Brain Neoplasms
• Share to Exome